PT  - JOURNAL ARTICLE
AU  - Lampert, Adam
AU  - Sulitzeanu-Kenan, Raanan
AU  - Vanhuysse, Pieter
AU  - Tepe, Markus
TI  - The rich-to-poor vaccine donation game: When will self-interested countries donate their surplus vaccines during pandemics?
AID  - 10.1101/2021.12.30.21268537
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.30.21268537
4099  - http://medrxiv.org/content/early/2021/12/30/2021.12.30.21268537.short
4100  - http://medrxiv.org/content/early/2021/12/30/2021.12.30.21268537.full
AB  - When will self-interested vaccine-rich countries voluntarily donate their surplus vaccines to vaccine-poor countries during a pandemic? We develop a game-theoretic approach to address this question. We identify vaccine-rich countries’ optimal surplus donation strategies, and then examine whether these strategies are stable (Nash equilibrium or self-enforcing international agreement). We identify parameter ranges in which full or partial surplus stock donations are optimal for the donor countries. Within a more restrictive parameter region, these optimal strategies are also stable. This implies that, under certain conditions (notably a total amount of surplus vaccines that is sufficiently large), simple coordination can lead to significant donations by strictly self-interested vaccine-rich countries. On the other hand, if the total amount that the countries can donate is small, we expect no contribution from self-interested countries. The results of this analysis provide guidance to policy makers in identifying the circumstances in which coordination efforts are likely to be effective.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Volkswagen Stiftung "Corona Crisis and Beyond - Perspectives for Science, Scholarship and Society".Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript